Healthcare quant check: RLAY and TNGX lead Seeking Alpha's top picks ahead of Q1 earnings
Source: SeekingAlpha
2026-04-07 11:05:55 ET
More on healthcare sector:
- Routine Vaccines Okay For Now: Investment Implications Of The Court Decision
- Sector Rotation: Healthcare XLV Should Be The Next Stop
- VT: Still The Best Approach To Passive Investing
- Roth Capital Partners flags caution as markets enter Q2
- Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Read the full article on Seeking Alpha
For further details see:
Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings
Astellas Pharma Inc. ADR
NASDAQ: ALPMY
ALPMY Trading
-0.42% G/L:
$13.39 Last:
82,071 Volume:
$13.4984 Open:
ALPMY Latest News
January 08, 2026 10:30:00 am
VYLOY(TM) (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses
December 17, 2025 06:45:00 am
PADCEV(TM) Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
December 10, 2025 06:30:00 pm
Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium
ALPMY Stock Data
$29,447,472,947
1,772,218,737
N/A
5
N/A
Pharmaceuticals
Healthcare
JP
Chuo-Ku
